-
The most common mistakes in digital trials (and how to avoid them)
There’s one thing no one admits openly, but anyone working in digital trials has learned the hard way: technology is brilliant when everything is under control, and ruthless the moment something slips. In digital environments (wearables, ePRO, platforms, real-time data), weak signals don’t exist. Every error grows. Every ambiguity multiplies. Every uncertainty becomes impossible to hide.…
-
How Risk-Based thinking drives digital trials
In recent years, clinical research has embraced a new vocabulary: decentralized, remote, hybrid, digitalized, connected. Terms that once belonged to the future now define our daily operations. With hybrid models (combining onsite visits with remote data collection) and the growing adoption of connected devices, ePRO platforms, study portals, and workflow management systems, clinical trials have…
-
Ready for the next draft: what will change in the regulation of AI medical devices by 2026
There’s a silent revolution underway in the way we regulate Artificial Intelligence in medicine. For years, the conversation has been all about validation: collecting data, measuring performance, defining protocols, proving that the model works.The logic was linear: if it works, it can be certified. But 2026 marks a turning point.It will no longer be enough…
-
Beyond automation: when technology takes shape around people
There’s a moment at the start of every clinical project when everything begins to take shape.A protocol comes to life, timelines become real, and a team starts building trust. That’s the moment technology enters the picture: not to dictate the rules, but to listen. Because no matter how advanced a platform is, technology only makes…
-
The Expert Take | When RCTs aren’t the best choice: finding the right study design for Medical Devices
“RCTs are the gold standard.” That’s the mantra we all know in clinical research, and it’s true. Or rather, almost true. Because when it comes to medical devices, that model starts to crack.Devices live in a reality that’s dynamic, operator-dependent, and constantly evolving.Recognizing when an RCT isn’t the right choice doesn’t mean lowering the bar: it means…
-
FDA vs EU: how to keep up with confusing regulations
Future is now. What we used to imagine as something for the year 3000 is already here, woven into our everyday life. Technology has reshaped our habits so profoundly that it’s hard to remember how things worked before. In clinical research, this transformation has been nothing short of pivotal. From Artificial Intelligence (AI) to Software…
-
When Tech meets Empathy: Designing tools that truly works for people
“The great myth of our times is that technology is communication.” – Libby Larsen We often celebrate technological progress as if it were an end in itself. But in clinical research, tech that doesn’t connect with people quickly shows its limits.True innovation happens when technology and empathy work together, enabling research teams not just to…
-
MDR 2025: What’s Really Changing and How to Prepare Now
The MDR deadline extension is not a pause. It’s a strategic opportunity – but only if you act early. Back in early 2024, the European Commission granted more time for companies to align with Regulation (EU) 2017/745 (MDR) – particularly concerning legacy devices. While many manufacturers welcomed the extra breathing room, be careful: more time doesn’t mean fewer…
-
GCP R3 – Episode 1: What you need to know (Especially if you work in MedTech)
GCP R3: GCP is evolving, are you? The ICH has released the E6(R3) revision of Good Clinical Practice (GCP), and it marks a turning point. With this update, the rules of clinical evidence have changed, and if you’re working on medical devices, SaMD or digital health, you’re in the game now too. No need to worry, here’s a…
-
MDR – Racing Against Time for Your CE Mark
The extension is here, but it’s not a safety net. Learn how to move fast, stay compliant, and protect your market share. With Regulation (EU) 2023/607, the European Commission has introduced a critical extension to MDR deadlines for legacy devices certified under the previous MDD (Directive 93/42/EEC). It’s a valuable opportunity—but not an excuse to delay.…
